查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1448820

全球兒科藥物市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Pediatric Medicines Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 201 Pages | 商品交期: 最快1-2個工作天內

價格

全球兒科藥品市場需求預計將從 2023 年的 52.2 億美元增至 2032 年的近 88.7 億美元，2024-2032 年研究期間複合CAGR為 6.07%。

兒科藥物是專門為治療兒童和嬰兒而設計和配製的藥物製劑。這些藥物考慮了年齡、體重和發育階段，以確保安全性和有效性。兒科製劑可能包括液體、咀嚼錠或特殊包衣丸劑以方便給藥。兒科藥物的開發對於滿足兒童獨特的醫療保健需求、提供準確的劑量和適口的配方以提高依從性和整體治療效果至關重要。

市場動態

人們對兒童保健的日益關注以及對兒科特定醫療需求的認知不斷增強，推動了兒科藥品市場的發展。兒科人口的增加、兒科藥物配方的進步以及解決兒童未滿足的醫療需求的措施等因素都有助於市場成長。對兒科藥物開發和擴大兒科臨床試驗的監管激勵措施也極大地推動了兒科藥物的創新。此外，兒童慢性病的流行以及對適合年齡的配方和劑型的需求也推動了兒科藥品市場的發展。針對各種兒科疾病（包括感染、呼吸系統疾病和神經發育障礙）對安全有效藥物的需求，進一步推動了兒科醫療保健領域的研究和開發活動。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球兒科藥品市場的各個細分市場進行了包容性評估。兒科藥品行業的成長和趨勢為本研究提供了整體方法。

市場區隔

兒科藥品市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

依藥物類型

  • 呼吸系統疾病醫學
  • 自體免疫疾病醫學
  • 心血管醫學
  • 胃腸道藥物

依疾病類型

  • 呼吸疾病
  • 傳染性疾病
  • 中樞神經系統疾病
  • 胃腸道疾病
  • 腫瘤疾病
  • 其他

依給藥途徑

  • 口服
  • 專題
  • 注射用
  • 其他

按配銷通路

  • 醫院藥房
  • 零售藥局
  • 網路藥局

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲兒科藥品市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。兒科藥品市場的主要參與者包括諾華公司、葛蘭素史克公司、輝瑞公司、默克公司、阿斯特捷利康公司、強生公司、賽諾菲公司、羅氏控股公司、梯瓦製藥工業公司、禮來公司、諾和諾德公司、勃林格殷格翰、百時美施貴寶、艾伯維公司等。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：兒科藥物 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按藥品類型分類的市場吸引力分析
    • 按疾病類型分類的市場吸引力分析
    • 按給藥途徑進行的市場吸引力分析
    • 按配銷通路分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球兒科藥品市場分析：依藥品類型

  • 按藥物類型概述
  • 歷史和預測數據
  • 依藥物類型分析
  • 呼吸系統疾病醫學
  • 自體免疫疾病醫學
  • 心血管醫學
  • 胃腸道藥物

第 6 章：全球兒科藥物市場分析：依疾病類型

  • 依疾病類型概述
  • 歷史和預測數據
  • 依疾病類型分析
  • 呼吸疾病
  • 傳染性疾病
  • 中樞神經系統疾病
  • 胃腸道疾病
  • 腫瘤疾病
  • 其他

第 7 章：全球兒科藥物市場分析：依給藥途徑

  • 依給藥途徑概述
  • 歷史和預測數據
  • 依給藥途徑分析
  • 口服
  • 專題
  • 注射用
  • 其他

第 8 章：全球兒科藥品市場分析：按分銷管道

  • 按配銷通路分類的概覽
  • 歷史和預測數據
  • 按配銷通路分析
  • 醫院藥房
  • 零售藥局
  • 網路藥局

第 9 章：全球兒科藥品市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 10 章：兒科藥品公司的競爭格局

  • 兒科藥品市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章：公司簡介

  • 公司股份分析
  • 市場集中度
  • Novartis AG
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • GlaxoSmithKline
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Pfizer Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Merck & Co.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • AstraZeneca
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Johnson & Johnson
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Sanofi
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Roche Holding AG
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Teva Pharmaceutical Industries
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Eli Lilly and Company
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Novo Nordisk A/S
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Boehringer Ingelheim
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Bristol-Myers Squibb
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • AbbVie Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Others.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

Product Code: VMR112113829

The global demand for Pediatric Medicines Market is presumed to reach the market size of nearly USD 8.87 Billion by 2032 from USD 5.22 Billion in 2023 with a CAGR of 6.07% under the study period 2024 - 2032.

Pediatric medicines are pharmaceutical formulations specifically designed and formulated for treating children and infants. These medicines consider age, weight, and developmental stages to ensure safety and effectiveness. Pediatric formulations may include liquids, chewable tablets, or specially coated pills to facilitate administration. The development of pediatric medicines is crucial for addressing the unique healthcare needs of children, providing accurate dosages and palatable formulations to enhance compliance and overall therapeutic outcomes.

MARKET DYNAMICS

The increasing focus on child healthcare and the growing awareness of pediatric-specific medical needs drives the pediatric medicines market. Factors such as rising pediatric populations, advancements in pediatric medicine formulations, and initiatives to address unmet medical needs in children contribute to market growth. Regulatory incentives for pediatric drug development and expanding pediatric clinical trials also significantly drive innovation in pediatric medicines. Additionally, the prevalence of chronic diseases in children and the demand for age-appropriate formulations and dosage forms boost the pediatric medicines market. The need for safe and effective medications for various pediatric conditions, including infections, respiratory disorders, and neurodevelopmental disorders, further propels research and development activities in the pediatric healthcare sector.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of pediatric medicines. The growth and trends of pediatric medicines industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the pediatric medicines market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type Of Medicine

  • Respiratory Disorder Medicine
  • Autoimmune Disorder Medicine
  • Cardiovascular Medicine
  • Gastrointestinal Medicines

By Type Of Disease

  • Respiratory Diseases
  • Infectious Diseases
  • Cns Diseases
  • Gastrointestinal Diseases
  • Oncological Diseases
  • Others

By Route Of Administration

  • Oral
  • Topical
  • Parenteral
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Pediatric Medicines market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Pediatric Medicines market include Novartis AG, GlaxoSmithKline, Pfizer Inc., Merck & Co., AstraZeneca, Johnson & Johnson, Sanofi, Roche Holding AG, Teva Pharmaceutical Industries, Eli Lilly and Company, Novo Nordisk A/S, Boehringer Ingelheim, Bristol-Myers Squibb, AbbVie Inc., and others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . PEDIATRIC MEDICINES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type of Medicine
    • 3.7.2 Market Attractiveness Analysis By Type of Disease
    • 3.7.3 Market Attractiveness Analysis By Route of Administration
    • 3.7.4 Market Attractiveness Analysis By Distribution Channel
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL PEDIATRIC MEDICINES MARKET ANALYSIS BY TYPE OF MEDICINE

  • 5.1 Overview by Type of Medicine
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type of Medicine
  • 5.4 Respiratory Disorder Medicine Historic and Forecast Sales by Regions
  • 5.5 Autoimmune Disorder Medicine Historic and Forecast Sales by Regions
  • 5.6 Cardiovascular Medicine Historic and Forecast Sales by Regions
  • 5.7 Gastrointestinal Medicines Historic and Forecast Sales by Regions

6 . GLOBAL PEDIATRIC MEDICINES MARKET ANALYSIS BY TYPE OF DISEASE

  • 6.1 Overview by Type of Disease
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Type of Disease
  • 6.4 Respiratory Diseases Historic and Forecast Sales by Regions
  • 6.5 Infectious Diseases Historic and Forecast Sales by Regions
  • 6.6 CNS Diseases Historic and Forecast Sales by Regions
  • 6.7 Gastrointestinal Diseases Historic and Forecast Sales by Regions
  • 6.8 Oncological Diseases Historic and Forecast Sales by Regions
  • 6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL PEDIATRIC MEDICINES MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 7.1 Overview by Route of Administration
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Route of Administration
  • 7.4 Oral Historic and Forecast Sales by Regions
  • 7.5 Topical Historic and Forecast Sales by Regions
  • 7.6 Parenteral Historic and Forecast Sales by Regions
  • 7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL PEDIATRIC MEDICINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1 Overview by Distribution Channel
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Distribution Channel
  • 8.4 Hospital Pharmacies Historic and Forecast Sales by Regions
  • 8.5 Retail Pharmacies Historic and Forecast Sales by Regions
  • 8.6 Online Pharmacies Historic and Forecast Sales by Regions

9 . GLOBAL PEDIATRIC MEDICINES MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. South East Asia Sales Analysis
    • 9.5.10. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE PEDIATRIC MEDICINES COMPANIES

  • 10.1. Pediatric Medicines Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF PEDIATRIC MEDICINES INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Novartis AG
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. GlaxoSmithKline
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Pfizer Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Merck & Co.
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. AstraZeneca
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Johnson & Johnson
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Sanofi
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Roche Holding AG
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Teva Pharmaceutical Industries
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Eli Lilly and Company
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. Novo Nordisk A/S
    • 11.13.1. Company Overview
    • 11.13.2. Company Revenue
    • 11.13.3. Products
    • 11.13.4. Recent Developments
  • 11.14. Boehringer Ingelheim
    • 11.14.1. Company Overview
    • 11.14.2. Company Revenue
    • 11.14.3. Products
    • 11.14.4. Recent Developments
  • 11.15. Bristol-Myers Squibb
    • 11.15.1. Company Overview
    • 11.15.2. Company Revenue
    • 11.15.3. Products
    • 11.15.4. Recent Developments
  • 11.16. AbbVie Inc.
    • 11.16.1. Company Overview
    • 11.16.2. Company Revenue
    • 11.16.3. Products
    • 11.16.4. Recent Developments
  • 11.17. Others.
    • 11.17.1. Company Overview
    • 11.17.2. Company Revenue
    • 11.17.3. Products
    • 11.17.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type of Medicine (USD MN)
  • Respiratory Disorder Medicine Market Sales by Geography (USD MN)
  • Autoimmune Disorder Medicine Market Sales by Geography (USD MN)
  • Cardiovascular Medicine Market Sales by Geography (USD MN)
  • Gastrointestinal Medicines Market Sales by Geography (USD MN)
  • Analysis Market by Type of Disease (USD MN)
  • Respiratory Diseases Market Sales by Geography (USD MN)
  • Infectious Diseases Market Sales by Geography (USD MN)
  • CNS Diseases Market Sales by Geography (USD MN)
  • Gastrointestinal Diseases Market Sales by Geography (USD MN)
  • Oncological Diseases Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Route of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Topical Market Sales by Geography (USD MN)
  • Parenteral Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Online Pharmacies Market Sales by Geography (USD MN)
  • Global Pediatric Medicines Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Pediatric Medicines Report
  • Market Research Process
  • Market Research Methodology
  • Global Pediatric Medicines Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type of Medicine
  • Market Attractiveness Analysis by Type of Disease
  • Market Attractiveness Analysis by Route of Administration
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type of Medicine (USD MN)
  • Respiratory Disorder Medicine Market Sales by Geography (USD MN)
  • Autoimmune Disorder Medicine Market Sales by Geography (USD MN)
  • Cardiovascular Medicine Market Sales by Geography (USD MN)
  • Gastrointestinal Medicines Market Sales by Geography (USD MN)
  • Global Market Analysis by Type of Disease (USD MN)
  • Respiratory Diseases Market Sales by Geography (USD MN)
  • Infectious Diseases Market Sales by Geography (USD MN)
  • CNS Diseases Market Sales by Geography (USD MN)
  • Gastrointestinal Diseases Market Sales by Geography (USD MN)
  • Oncological Diseases Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Route of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Topical Market Sales by Geography (USD MN)
  • Parenteral Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Online Pharmacies Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.